Modulation of bleomycin-induced lung fibrosis by pegylated Hyaluronidase and dopamine receptor antagonist in mice

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Skurikhin, Evgenii Germanovich ^a   Pershina, Olga Victorovna ^a   Reztsova, Alena Mikhaylovna ^a   Ermakova, Natalia Nikolaevna ^a   Khmelevskaya, Ekaterina Sergeevna ^a   Krupin, Vycheslav Andreevich ^a   Stepanova, Inna Ernestovna ^a   Artamonov, Andrew Vladimirovich ^b   Bekarev, Andrew Alexandrovich ^b   Madonov, Pavel Gennadjevich ^b   Dygai, Alexander Mikhaylovich ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b Scientific Futures Management Company   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BLEOMYCIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; INTERLEUKIN 1BETA; PEGYLATED HYALURONIDASE; POLYETHYLENE; SPIPERONE; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; HYALURONOGLUCOSAMINIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFIBROTIC ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; BONE MARROW CELL; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; IMMUNOPHENOTYPING; IRREVERSIBLE PULMONARY FIBROSIS; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PNEUMOFIBROSIS; PROTEIN HYDROLYSIS; RECEPTOR BLOCKING; REVERSIBLE PULMONARY FIBROSIS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; PULMONARY FIBROSIS;

ANIMALS; BLEOMYCIN; DOPAMINE ANTAGONISTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HYALURONOGLUCOSAMINIDASE; MALE; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; SPIPERONE;

EID: 84957837236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125065     Document Type: Article

References (98)

1. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011 Jul. 4;208(7):1339-1350. doi: 10.1084/jem.20110551 PMID: 21727191
2. Hubbard R, Cooper M, Antoniak M, Venn A, Khan S, Johnston I, et al. Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet. 2000 Feb. 5;355(9202):466-467. PMID: 10841131
3. Baumgarter KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol. 2000 Aug. 15;152(4):307-315. PMID: 10968375
4. Weissman DN. Silicosis. In Interstitial lung disease. Edited by Schwarz MI, King TE. 4th edition. Ontario (Canada): BC Decker; 2003. pp. 387-401.
5. Banks DE. Coal workers' pneumoconiosis. In Interstitial lung disease. Edited by Schwarz MI, King TE. 4th edition. Ontario (Canada): BC Decker; 2003. pp. 402-417.
6. Steele M, Peterson MW, Schwarz DA. Asbestosis and asbestos-induced pleural fibrosis. In Interstitial lung disease. Edited by Schwarz MI, King TE. 4th edition. Ontario (Canada); 2003. pp. 418-434.
7. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc. 2006 Jun; 3(4):293-298. PMID: 16738192
8. Gustafson T, Dahlman-Höglund A, Nilsson K, Ström K, Tornling G, Torén K. Occupational exposure and severe pulmonary fibrosis. Respir Med. 2007 Oct; 101(10):2207-2212. PMID: 17628464
9. Pinheiro GA, Antao VC, Wood JM, Wassell JT. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. Int J Occup Environ Health. 2008 Apr-Jun; 14(2):117-123. PMID: 18507288
10. Denham JW, Hauer-Jensen M. The radiotherapeutic injury-A complex 'wound'. Radiother Oncol. 2002 May; 63(2):129-145. PMID: 12063002
11. Kelly BG, Lok SS, Hasleton PS, Egan JJ, Stewart JP. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002 Aug. 15;166(4):510-513. PMID: 12186829
12. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 2003;34:1507-1516. PMID: 12788471
13. Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat. Rev. Cancer. 2005 Feb; 5(2):102-112. PMID: 15685195
14. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001; Jan 16;134(2):136-151. PMID: 11177318
15. Tzilas V, Koti A, Papandrinopoulou D, Tsoukalas G. Prognostic factors in idiopathic pulmonary fibrosis. Am J Med Sci. 2009; Dec; 338(6):481-485. doi: 10.1097/MAJ.0b013e3181ad5984 PMID: 19826245
16. Mahendran S, Sethi T. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach? QJM. 2012; Oct; 105(10):929-934. PMID: 22647761
17. Khalil N, O'Connor R. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ. 2004 Jul. 20;171(2):153-160. PMID: 15262886
18. Kemparaju K, Girish KS. Snake venom hyaluronidase: a therapeutic target. Cell Biochem Funct. 2006 Jan-Feb; 24(1):7-12. PMID: 16245359
19. Bitencourt CS, Pereira PA, Ramos SG, Sampaio SV, Arantes EC, Aronoff DM, et al. Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis. Fibrogenesis & Tissue Repair. 2011;4(1):3. doi: 10.1186/1755-1536-4-3
20. Hinds KD. Protein conjugation, cross-linking, and PEGylation: biomaterials for Delivery and Targeting of Proteins and Nucleic Acids. Edited by Mahato RI, CRC Press, Boca Raton, Fla, USA; 2005. pp. 119-185.
21. Filpula D, Zhao H. Releasable PEGylation of proteins with customized linkers. Advanced Drug Delivery Reviews. 2008;60(1):29-49. PMID: 17884239
22. Khandare J, Minko T. Polymer-drug conjugates: progress in polymeric prodrugs. Progress in Polymer Science. 2006;31(4):359-397.
23. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angewandte Chemie-International Edition. 2010;49(36):6288-6308. doi: 10.1002/anie.200902672 PMID: 20648499
24. Amenta F, Ricci A, Tayebati SK, Zaccheo D. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital. J. Anat. Embryol. 2002;107:145-167. PMID: 12437142
25. Kobayashi Y, Ricci A, Amenta F, Cavallotti C, Hattori K. Localization of dopamine receptors in the rabbit lung vasculature. J. Vasc. Res. 1995;3(2):200-206.
26. 2)) receptors within the rabbit pulmonary circulation. Pulm Pharmacol Ther. 2002;14:393-398.
27. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Aronoff DM, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003;100:8407-8411. PMID: 12815096
28. Dygai AM, Skurikhin EG, Andreeva TV, Ermolaeva LA, Khmelevskaya ES, Pershina OV, et al. Reactions of the blood system and stem cells in bleomycin-induced model of lung fibrosis. Bull Exp Biol Med. 2011 Dec. 152(2):173-176. doi: 10.1007/s10517-011-1480-z PMID: 22808452
29. Skurikhin EG, Pershina OV, Khmelevskaya ES, Ermakova NN, Reztsova AM, Krupin VA, et al. Modulation of Stem and Progenitor Cells and Bleomycin-induced Pulmonary Fibrosis by Spiperone in Mice. J Stem Cell Res Ther. 2014;4:210. doi: 10.4172/2157-7633.1000210
30. Prentø P. Van Gieson's picrofuchsin. The staining mechanisms for collagen and cytoplasm, and an examination of the dye diffusion rate model of differential staining. Histochemistry. 1993;99(2):163-174. PMID: 7683012
31. Singh M, Chaudhary AK, Pandya S, Debnath S, Singh M, Singh PA, et al. Morphometric analysis in potentially malignant head and neck lesions: oral submucous fibrosis. Asian Pac J Cancer Prev. 2010;11(1):257-260. PMID: 20593967
32. Usuki J, Fukuda Y. Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol Int. 1995;45:552-564. PMID: 7496500
33. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83(3):111-119. PMID: 12383190
34. Chua F., Gauldie J., Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol. 2005;33(1):9-13. PMID: 15964990
35. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem, Cell Biol. 2008;40(3):362-382. doi: 10.1016/j.biocel.2007.08.011 PMID: 17936056
36. Jung D, Garat C, West J, Thorn N, Chow K, Cleaver T, et al. The Pathology of Bleomycin induced Fibrosis is Associated with Loss of Resident Lung Mesenchymal Stem cells which Regulate Effector T-cell Proliferation. Stem Cells. 2011 Apr. 29(4):725-735. doi: 10.1002/stem.604 PMID: 21312316
37. Ratajczak MZ. Phenotypic and functional characterization of hematopoietic stem cells. Curr Opin Hematol. 2008;15(4):293-300. doi: 10.1097/MOH.0b013e328302c7ca PMID: 18536565
38. Xynos A, Corbella P, Belmonte N, Zini R, Manfredini R, Ferrari G. Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway. Stem Cells. 2010 May 28(5):965-973. doi: 10.1002/stem.418 PMID: 20333749
39. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003 Oct. 23;425(6960):836-841. PMID: 14574412
40. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haemopoietic stem cell niche. Nature. 2003 Oct. 23;425(6960):841-846. PMID: 14574413
41. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. A hypothesis. Blood cells. 1978;4(1-2):7-25. PMID: 747779
42. Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000 Feb. 25;287(5457):1427-1430. PMID: 10688781
43. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature. 2001 Nov. 1;414(6859):98-104. PMID: 11689954
44. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005 Jul. 1;121(7):1109-1121. PMID: 15989959
45. Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell. 2009 Mar. 6;4(3):263-274. doi: 10.1016/j.stem.2009.01.006 PMID: 19265665
46. Xie Y, Yin T, Wiegraebe W, He XC, Miller D, Stark D, et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature. 2009 Jan 1;457(7225):97-101. doi: 10.1038/nature07639 PMID: 19052548
47. Rodriguez S, Chora A, Goumnerov B, Mumaw C, Goebel WS, Fernandez L, et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood. 2009 Nov. 5;114(19):4064-4076. doi: 10.1182/blood-2009-04-214916 PMID: 19696201
48. Scumpia PO, Kelly-Scumpia KM, Delano MJ, Weinstein JS, Cuenca AG, Al-Quran S, et al. Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol. 2010;184(5):2247-2251. doi: 10.4049/jimmunol.0903652 PMID: 20130216
49. Kolb-Mäurer A, Weissinger F, Kurzai O, Mäurer M, Wilhelm M, Goebel W. Bacterial infection of human hematopoietic stem cells induces monocytic differentiation. FEMS Immunol Med Microbiol. 2004;40(2):147-153. PMID: 14987733
50. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity. 2006;24(6):801-812. PMID: 16782035
51. De Luca K, Frances-Duvert V, Asensio MJ, Ihsani R, Debien E, Taillardet M, et al. The TLR1/2 agonist PAM (3) CSK (4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia. 2009;23(11):2063-2074. doi: 10.1038/leu.2009.155 PMID: 19641520
52. Esplin BL, Shimazu T, Welner RS, Garrett KP, Nie L, Zhang Q, et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol. 2011;186(9):5367-5375. doi: 10.4049/jimmunol. 1003438 PMID: 21441445
53. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA, et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell. 2007; Nov. 30;131(5):994-1008. PMID: 18045540
54. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature. 2010; Jun. 10;465(7299):793-797. doi: 10.1038/nature09135 PMID: 20535209
55. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871-1875. PMID: 11729303
56. Le Blanc K, Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy. 2005;7(1):36-45. PMID: 16040382
57. Siniscalco D, Sullo N, Maione S, Rossi F, D'Agostino B. Stem cell therapy: the great promise in lung disease. Ther Adv Respir Dis. 2008; Jun; 2(3):173-177. doi: 10.1177/1753465808092340 PMID: 19124369
58. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, et al. Human umbilical cord mesenchymal stem cell reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009;175:303-313. doi: 10.2353/ajpath.2009.080629 PMID: 19497992
59. Savani RC, Hou G, Liu P, Wang C, Simons E, Grimm PC, et al. A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am J Respir Cell Mol Biol. 2000 Oct; 23(4):475-484. PMID: 11017912
60. Dentener MA, Vernooy JH, Hendriks S, Wouters EF. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax. 2005; Feb; 60(2):114-196. PMID: 15681498
61. Jiang D, Liang J, Noble WP. Hyaluronan in Tissue Injury and Repair. Annu Rev Cell Dev Biol. 2007;23:435-461. PMID: 17506690
62. Toole BP, Trelstad RL. Hyaluronate production and removal during corneal development in the chick. Developmental Biology. 1971;26(1):28-35. PMID: 5111769
63. Pratt RM, Larsen MA, Johnston MC. Migration of cranial neural crest cells in a cell-free hyaluronate-rich matrix. Developmental Biology. 1975;44(2):298-305. PMID: 1132595
64. Christophis C, Taubert I, Meseck GR, Schubert M, Grunze M, Ho AD, et al. Shear stress regulates adhesion and rolling of CD44+ leukemic and hematopoietic progenitor cells on hyaluronan. Biophysicol Journal. 2011;101(3):585-593. doi: 10.1016/j.bpj.2011.05.045 PMID: 21806926
65. Jha AK, Xu X, Duncan RL, Jia X. Controlling the adhesion and differentiation of mesenchymal stem cells using hyaluronic acid-based, doubly crosslinked networks. Biomaterials. 2011;32(10):2466-2478. doi: 10.1016/j.biomaterials.2010.12.024 PMID: 21216457
66. Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech A. Hyaluronan: fundamental principles and applications in cancer. J Intern Med. 1997;242:41-48. PMID: 9260565
67. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003; Jul; 200(4):500-503. PMID: 12845617
68. Kadler KE, Hill A, Canty-Laird Curr EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008; Oct; 20(5):495-501. doi: 10.1016/j.ceb. 2008.06.008 PMID: 18640274
69. Wenzel SE, Trudeau JB, Barnes S, Zhou X, Cundall M, Westcott JY, et al. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol. 2002;169:4613-4619. PMID: 12370400
70. Malavia NK, Mih JD, Raub CB, Dinh BT, George SC. IL-13 induces a bronchial epithelial phenotype that is profibrotic. Respir Res. 2008; Mar. 18;9:27. doi: 10.1186/1465-9921-9-27 PMID: 18348727
71. Ito T, Williams JD, Fraser DJ, Phillips AO. Hyaluronan regulates transforming growth factor-beta1 receptor compartmentalization. J Biol Chem. 2004; Jun. 11;279(24):25326-25332. PMID: 15084590
72. Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res. 2000;257:180-189. PMID: 10854066
73. Webber J, Meran S, Steadman R, Phillips A. Hyaluronan orchestrates transforming growth factorbeta1-dependent maintenance of myofibroblast phenotype. J Biol Chem. 2009; Apr. 3;284(14):9083-92. doi: 10.1074/jbc. M806989200 PMID: 19193641
74. Ortiz LA, Lasky J Jr, Hamilton RF Jr, Holian A, Hoyle GW, Banks W, et al. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res. 1998;24:721-743. PMID: 9839161
75. Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H. Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice. Am J Respir Cell Mol Biol. 2009;41:661-670. doi: 10.1165/rcmb.2008-0182OC PMID: 19265174
76. Loebinger MR, Aguilar S, Janes SM. Therapeutic potential of stem cells in lung disease: progress and pitfalls. Clin Sci (Lond). 2008; Jan; 114(2):99-108. PMID: 18062775
77. Bosing-Schneider R, Haug M. Role of cyclic AMP on differentiation of T- and B-lymphocytes during the immune induction. Cell. Immunology. 1976;27:121-125. PMID: 186196
78. Depelchin A, Letesson JJ. Adrenaline influence on the immune response. II. Its effects through action on the suppressor T cells. Immunol Lett. 1981 Oct; 3(4):207-213. PMID: 6273303
79. Landman RM, Burgisser E, Wesp M, Bühler FR. Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes. J Recept Res. 1984;4:37-50. PMID: 6098662
80. Miles K, Atwen S, Otten G, Arnason BG, Chelmicka-Schorr E. Beta-adrenergic receptors on splenic lymphocytes from axotomized mice. Int J Immunopharmacol. 1984;6(3):171-177. PMID: 6086537
81. Van Furth R. Phagocytic cells in the defense against infection: introduction. Rev Infect Dis. 1980;2:104-105.
82. Hall NR, Goldstain AL. Neurotransmitters and the immune system. In Ader R. (Ed)/Psychoneuroimmunology: N Y Academic Press; 1981. pp. 521-526.
83. Weinstock JV, Blum AM. Tachykinin production by granuloma eosinophils in murine schistosomiasis mansoni. J Immunol. 1989;142:3256-3266. PMID: 2496164
84. Zahniser NR, Bier-Laning CM, Gerber JG, Nies AS. Timolol-induced up-regulation of polymorphonuclear leukocyte β2-adrenergic receptors in the elderly. Clin Pharmacol Ther. 1989 May; 45(5):469-475. PMID: 2541960
85. Bringardner BD, Baran CP, Eubank TD, Marsh CB. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal. 2008 Feb; 10(2):287-301. PMID: 17961066
86. Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int. 2001 Feb; 59(2):579-592. PMID: 11168939
87. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425-456. PMID: 12615888
88. Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 2006;3:357-363. PMID: 16738201
89. Morley A, Quesenberry P, Garrity M, Stohlman F Jr. Inhibition of marrow growth by cyclic AMP. Proc Soc Exp Biol Med. 1971 Oct; 138(1):57-59. PMID: 4331097
90. Byron JW. Cell mechanism influencing the transition of hemopoietic stem cells from Go into S//Cell cycle controls. In: Padilles GM, Cameron IL, Zimmerman A.; N. Y. 1974. pp. 97-99.
91. Brown JE, Adamson JW. Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest. 1977; Jul; 60(1):70-77. PMID: 17618
92. Mladenovic J, Adamson JW. Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. Br J Haematol. 1984; Feb; 56(2):323-332. PMID: 6691924
93. Skurikhin EG, Khmelevskaya ES, Pershina OV, Ermakova NN, Krupin VA, Ermolaeva LA, et al. Anti-fibrotic Effect of Reserpine on Lung Fibrosis: Stem Cells in the Pathogenesis of Pneumofibrosis. The Open Conference Proceedings Journal. 2013;4:31-46. doi: 10.2174/2210289201304010031
94. Kobayashi Y, Ricci A, Amenta F, Cavallotti C, Hattori K. Localization of dopamine receptors in the rabbit lung vasculature. J Vasc Res. 1995;32:200-206. PMID: 7772680
95. Bruzzone P, D'Andrea V, Motta C, Cavallotti C. Occurrence of dopaminergic (D (2)) receptors within the rabbit pulmonary circulation. Pulm Pharmacol Ther. 2002;15:393-398. PMID: 12220945
96. Fabre A, Marchal-Sommé J, Marchand-Adam S, Quesnel C, Borie R, Dehoux M, et al. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur. Respir. J. 2008;32:426-436. doi: 10.1183/09031936.00126907 PMID: 18321937
97. Berg RA, Moss J, Baum BJ, Crystal RG. Regulation of collagen production by the beta-adrenergic system. Journal of Clinical Investigation, 1981;67:1457-1462. PMID: 6262376
98. Giri SN, Sanford DA, Robinson TW, Tyler NK. Impairment in coupled beta-adrenergic receptor and adenylate cyclase system during bleomycin-induced lung fibrosis in hamsters. Exp Lung Res. 1987;13(4):401-416. PMID: 2452079